EUVIMEDEUVIMED entdecken
Open Access

Activation of GABBR1 by New Ligand Valerate Transcriptionally Regulates ATF4-NRF2-CXCL13 Axis Mediating CD8 + T Cell Anti-Tumor Immunity

Zhiran Zhai, Jumin Huang, Jiayue Qiu, Yuwei Wang, Jin Liao, Chun Xie, Jiahui Xu, Zebo Jiang, Yajia Xie, Wenkang Ren, Yizhong Zhang, Haoxin Yan und 3 weitere

International Journal of Biological Sciences · 2026

DOI: 10.7150/ijbs.127859 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2026. Verfasst von Zhiran Zhai und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Faculty of Chinese Medicine & State Key Laboratory of Mechanism and Quality of Chinese Medicine, Dr. Neher's Biophysics Laborator…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Lung Neoplasms, Chemokine CXCL13, NF-E2-Related Factor 2. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesLung NeoplasmsChemokine CXCL13NF-E2-Related Factor 2Carcinoma, Non-Small-Cell LungActivating Transcription Factor 4HumansAnimalsCell Line, TumorMiceGene Expression Regulation, NeoplasticTumor Microenvironment

Stichwörter der Autor:innen

GABBR1anti-tumor immunitynon-small cell lung cancervalerate

Substanzen

Chemokine CXCL13NF-E2-Related Factor 2Activating Transcription Factor 4NFE2L2 protein, humanCXCL13 protein, human

Autor:innen und Institutionen

  • School of Pharmacy, Faculty of Chinese Medicine & State Key Laboratory of Mechanism and Quality of Chinese Medicine, Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, Macau University of Science and Techn…
  • Cancer Center, Faculty of Health Sciences, Ministry of Education (MOE) Frontiers Science Center for Precision Oncology, University of Macau, Macau, Macau SAR, China.
  • Zhuhai UM Science & Technology Research Institute, University of Macau, Hengqin, Macau SAR, China.
  • College of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
  • Department of Respiratory and Critical Care Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, China.
  • Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, China.

Zitieren

APA

Zhai, Z., Huang, J., Qiu, J., Wang, Y., Liao, J., Xie, C., Xu, J., Jiang, Z., Xie, Y., Ren, W., Zhang, Y., Yan, H., Wang, M., Huang, C., & Leung, E. L. H. (2026). Activation of GABBR1 by New Ligand Valerate Transcriptionally Regulates ATF4-NRF2-CXCL13 Axis Mediating CD8 + T Cell Anti-Tumor Immunity. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.127859

Vancouver

Zhai Z, Huang J, Qiu J, Wang Y, Liao J, Xie C, et al. Activation of GABBR1 by New Ligand Valerate Transcriptionally Regulates ATF4-NRF2-CXCL13 Axis Mediating CD8 + T Cell Anti-Tumor Immunity. International Journal of Biological Sciences. 2026. doi:10.7150/ijbs.127859

BibTeX
@article{Zhai2026,
  author = {Zhai, Zhiran and Huang, Jumin and Qiu, Jiayue and Wang, Yuwei and Liao, Jin and Xie, Chun and Xu, Jiahui and Jiang, Zebo and Xie, Yajia and Ren, Wenkang and Zhang, Yizhong and Yan, Haoxin and Wang, Meifang and Huang, Chen and Leung, Elaine Lai Han},
  title = {Activation of GABBR1 by New Ligand Valerate Transcriptionally Regulates ATF4-NRF2-CXCL13 Axis Mediating CD8 + T Cell Anti-Tumor Immunity},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  doi = {10.7150/ijbs.127859}
}
Kostenlos starten →